White House Adviser Argued With Dr. Fauci Over Anti-Malaria Drug

White House Trade and Manufacturing Policy Director Peter Navarro speaks during the daily briefing on COVID-19 at the White House on March 22, 2020. (Photo by ERIC BARADAT/AFP via Getty Images)
Start your day with TPM.
Sign up for the Morning Memo newsletter

White House trade adviser Peter Navarro reportedly had a heated dispute with Dr. Anthony Fauci, a key member of the White House Anti-Coronavirus Task Force, over the efficacy of hydroxychloroquine, an anti-malaria drug, against COVID-19 on Saturday.

An unnamed source told Axios that Navarro had claimed the drug showed a “clear therapeutic efficacy” during a meeting in the Situation Room, prompting Fauci to point out that adviser did not have hard data on the matter.

“What are you talking about?” Fauci asked, according to CNN.

The doctor reportedly said any evidence that hydroxychloroquine would be effective was purely anecdotal, a rebuttal that infuriated Navarro.

“That’s science, not anecdote,” the adviser, who had begun raising his voice, said in response.

“There has never been a confrontation in the task force meetings like the one yesterday,” the source told Axios

Latest News
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Investigations Desk:
Editor at Large:
General Counsel:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: